IDEXX Laboratories, Inc. (0J8P.L)
USD 470.48
(-0.04%)
USD 470.48
(-0.04%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.66 Billion USD | 8.72% |
| 2022 | 3.36 Billion USD | 4.73% |
| 2021 | 3.21 Billion USD | 18.79% |
| 2020 | 2.7 Billion USD | 12.45% |
| 2019 | 2.4 Billion USD | 8.75% |
| 2018 | 2.21 Billion USD | 12.4% |
| 2017 | 1.96 Billion USD | 10.91% |
| 2016 | 1.77 Billion USD | 10.83% |
| 2015 | 1.6 Billion USD | 7.81% |
| 2014 | 1.48 Billion USD | 7.9% |
| 2013 | 1.37 Billion USD | 6.47% |
| 2012 | 1.29 Billion USD | 6.13% |
| 2011 | 1.21 Billion USD | 10.45% |
| 2010 | 1.1 Billion USD | 6.96% |
| 2009 | 1.03 Billion USD | 0.74% |
| 2008 | 1.02 Billion USD | 11.0% |
| 2007 | 922.55 Million USD | 24.82% |
| 2006 | 739.11 Million USD | 15.83% |
| 2005 | 638.09 Million USD | 16.19% |
| 2004 | 549.18 Million USD | 15.38% |
| 2003 | 475.99 Million USD | 15.34% |
| 2002 | 412.67 Million USD | 6.89% |
| 2001 | 386.08 Million USD | 5.08% |
| 2000 | 367.43 Million USD | 3.15% |
| 1999 | 356.2 Million USD | 11.35% |
| 1998 | 319.9 Million USD | 21.63% |
| 1997 | 263 Million USD | -1.76% |
| 1996 | 267.7 Million USD | 41.94% |
| 1995 | 188.6 Million USD | 49.21% |
| 1994 | 126.4 Million USD | 35.77% |
| 1993 | 93.1 Million USD | 61.35% |
| 1992 | 57.7 Million USD | 89.18% |
| 1991 | 30.5 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1 Billion USD | 4.1% |
| 2024 Q1 | 964.09 Million USD | 6.93% |
| 2024 Q3 | 975.54 Million USD | -2.79% |
| 2023 Q1 | 900.19 Million USD | 8.64% |
| 2023 FY | 3.66 Billion USD | 8.72% |
| 2023 Q4 | 901.6 Million USD | -1.52% |
| 2023 Q3 | 915.52 Million USD | -2.98% |
| 2023 Q2 | 943.63 Million USD | 4.83% |
| 2022 Q1 | 836.54 Million USD | 4.43% |
| 2022 Q3 | 841.66 Million USD | -2.19% |
| 2022 Q2 | 860.54 Million USD | 2.87% |
| 2022 Q4 | 828.56 Million USD | -1.56% |
| 2022 FY | 3.36 Billion USD | 4.73% |
| 2021 Q3 | 810.42 Million USD | -1.9% |
| 2021 Q1 | 777.7 Million USD | 7.87% |
| 2021 Q2 | 826.14 Million USD | 6.23% |
| 2021 Q4 | 801.09 Million USD | -1.15% |
| 2021 FY | 3.21 Billion USD | 18.79% |
| 2020 Q1 | 626.33 Million USD | 3.45% |
| 2020 FY | 2.7 Billion USD | 12.45% |
| 2020 Q2 | 637.59 Million USD | 1.8% |
| 2020 Q3 | 721.78 Million USD | 13.21% |
| 2020 Q4 | 720.93 Million USD | -0.12% |
| 2019 FY | 2.4 Billion USD | 8.75% |
| 2019 Q1 | 576.05 Million USD | 4.85% |
| 2019 Q3 | 605.3 Million USD | -2.39% |
| 2019 Q2 | 620.1 Million USD | 7.65% |
| 2019 Q4 | 605.44 Million USD | 0.02% |
| 2018 Q2 | 580.75 Million USD | 8.02% |
| 2018 Q1 | 537.65 Million USD | 6.23% |
| 2018 Q3 | 545.44 Million USD | -6.08% |
| 2018 FY | 2.21 Billion USD | 12.4% |
| 2018 Q4 | 549.38 Million USD | 0.72% |
| 2017 Q3 | 491.97 Million USD | -3.33% |
| 2017 FY | 1.96 Billion USD | 10.91% |
| 2017 Q4 | 506.12 Million USD | 2.88% |
| 2017 Q2 | 508.94 Million USD | 10.16% |
| 2017 Q1 | 462.02 Million USD | 4.29% |
| 2016 Q4 | 442.99 Million USD | -1.18% |
| 2016 Q2 | 466.56 Million USD | 11.74% |
| 2016 Q3 | 448.3 Million USD | -3.91% |
| 2016 Q1 | 417.55 Million USD | 4.47% |
| 2016 FY | 1.77 Billion USD | 10.83% |
| 2015 Q1 | 382.47 Million USD | 8.67% |
| 2015 Q4 | 399.68 Million USD | -1.65% |
| 2015 Q3 | 406.38 Million USD | -1.68% |
| 2015 Q2 | 413.34 Million USD | 8.07% |
| 2015 FY | 1.6 Billion USD | 7.81% |
| 2014 Q1 | 360.2 Million USD | 1.73% |
| 2014 FY | 1.48 Billion USD | 7.9% |
| 2014 Q4 | 351.95 Million USD | -8.23% |
| 2014 Q3 | 383.52 Million USD | -1.69% |
| 2014 Q2 | 390.12 Million USD | 8.31% |
| 2013 Q2 | 352.58 Million USD | 6.17% |
| 2013 Q4 | 354.07 Million USD | 4.66% |
| 2013 Q3 | 338.29 Million USD | -4.05% |
| 2013 FY | 1.37 Billion USD | 6.47% |
| 2013 Q1 | 332.1 Million USD | 3.93% |
| 2012 Q3 | 315.47 Million USD | -6.01% |
| 2012 Q4 | 319.53 Million USD | 1.29% |
| 2012 Q1 | 322.67 Million USD | 5.04% |
| 2012 FY | 1.29 Billion USD | 6.13% |
| 2012 Q2 | 335.64 Million USD | 4.02% |
| 2011 Q1 | 292.67 Million USD | 3.14% |
| 2011 Q2 | 317.86 Million USD | 8.61% |
| 2011 FY | 1.21 Billion USD | 10.45% |
| 2011 Q4 | 307.2 Million USD | 2.08% |
| 2011 Q3 | 300.95 Million USD | -5.32% |
| 2010 Q1 | 268.52 Million USD | -0.67% |
| 2010 Q2 | 281.48 Million USD | 4.83% |
| 2010 Q4 | 283.75 Million USD | 5.24% |
| 2010 Q3 | 269.62 Million USD | -4.21% |
| 2010 FY | 1.1 Billion USD | 6.96% |
| 2009 FY | 1.03 Billion USD | 0.74% |
| 2009 Q2 | 265.72 Million USD | 12.38% |
| 2009 Q4 | 270.33 Million USD | 4.33% |
| 2009 Q3 | 259.12 Million USD | -2.48% |
| 2009 Q1 | 236.45 Million USD | -2.81% |
| 2008 Q2 | 280.57 Million USD | 12.65% |
| 2008 Q4 | 243.29 Million USD | -3.11% |
| 2008 FY | 1.02 Billion USD | 11.0% |
| 2008 Q1 | 249.07 Million USD | 1.68% |
| 2008 Q3 | 251.09 Million USD | -10.51% |
| 2007 FY | 922.55 Million USD | 24.82% |
| 2007 Q4 | 244.96 Million USD | 6.79% |
| 2007 Q3 | 229.38 Million USD | -3.23% |
| 2007 Q2 | 237.04 Million USD | 12.26% |
| 2007 Q1 | 211.15 Million USD | 9.86% |
| 2006 Q2 | 191.36 Million USD | 13.8% |
| 2006 Q1 | 168.16 Million USD | 0.72% |
| 2006 FY | 739.11 Million USD | 15.83% |
| 2006 Q4 | 192.2 Million USD | 2.58% |
| 2006 Q3 | 187.38 Million USD | -2.08% |
| 2005 FY | 638.09 Million USD | 16.19% |
| 2005 Q3 | 158.06 Million USD | -1.59% |
| 2005 Q1 | 152.42 Million USD | 5.65% |
| 2005 Q4 | 166.97 Million USD | 5.63% |
| 2005 Q2 | 160.63 Million USD | 5.38% |
| 2004 Q2 | 137.37 Million USD | 2.97% |
| 2004 Q4 | 144.27 Million USD | 7.58% |
| 2004 FY | 549.18 Million USD | 15.38% |
| 2004 Q1 | 133.41 Million USD | 6.87% |
| 2004 Q3 | 134.11 Million USD | -2.38% |
| 2003 Q4 | 124.83 Million USD | 3.98% |
| 2003 Q2 | 121.84 Million USD | 11.53% |
| 2003 FY | 475.99 Million USD | 15.34% |
| 2003 Q1 | 109.24 Million USD | 3.17% |
| 2003 Q3 | 120.06 Million USD | -1.46% |
| 2002 FY | 412.67 Million USD | 6.89% |
| 2002 Q3 | 104.53 Million USD | -1.09% |
| 2002 Q1 | 96.55 Million USD | 1.49% |
| 2002 Q4 | 105.89 Million USD | 1.3% |
| 2002 Q2 | 105.69 Million USD | 9.47% |
| 2001 Q4 | 95.13 Million USD | -2.45% |
| 2001 FY | 386.08 Million USD | 5.08% |
| 2001 Q1 | 91.42 Million USD | -1.29% |
| 2001 Q2 | 102 Million USD | 11.57% |
| 2001 Q3 | 97.52 Million USD | -4.39% |
| 2000 Q4 | 92.61 Million USD | 2.47% |
| 2000 FY | 367.43 Million USD | 3.15% |
| 2000 Q3 | 90.38 Million USD | -3.39% |
| 2000 Q2 | 93.55 Million USD | 2.94% |
| 2000 Q1 | 90.87 Million USD | 2.57% |
| 1999 Q4 | 88.6 Million USD | 2.55% |
| 1999 FY | 356.2 Million USD | 11.35% |
| 1999 Q2 | 91.5 Million USD | 2.12% |
| 1999 Q1 | 89.6 Million USD | 8.34% |
| 1999 Q3 | 86.4 Million USD | -5.57% |
| 1998 FY | 319.9 Million USD | 21.63% |
| 1998 Q4 | 82.7 Million USD | 5.35% |
| 1998 Q3 | 78.5 Million USD | -2.97% |
| 1998 Q2 | 80.9 Million USD | 3.98% |
| 1998 Q1 | 77.8 Million USD | 8.36% |
| 1997 Q2 | 58.9 Million USD | -2.64% |
| 1997 Q1 | 60.5 Million USD | -18.9% |
| 1997 FY | 263 Million USD | -1.76% |
| 1997 Q4 | 71.8 Million USD | 0.14% |
| 1997 Q3 | 71.7 Million USD | 21.73% |
| 1996 Q3 | 69.8 Million USD | 5.92% |
| 1996 Q2 | 65.9 Million USD | 14.81% |
| 1996 Q1 | 57.4 Million USD | 5.9% |
| 1996 FY | 267.7 Million USD | 41.94% |
| 1996 Q4 | 74.6 Million USD | 6.88% |
| 1995 Q1 | 39.2 Million USD | 8.89% |
| 1995 FY | 188.6 Million USD | 49.21% |
| 1995 Q4 | 54.2 Million USD | 11.29% |
| 1995 Q2 | 46.5 Million USD | 18.62% |
| 1995 Q3 | 48.7 Million USD | 4.73% |
| 1994 Q4 | 36 Million USD | 12.85% |
| 1994 Q2 | 31.1 Million USD | 13.5% |
| 1994 Q3 | 31.9 Million USD | 2.57% |
| 1994 FY | 126.4 Million USD | 35.77% |
| 1994 Q1 | 27.4 Million USD | 2.24% |
| 1993 Q2 | 23.1 Million USD | 18.46% |
| 1993 FY | 93.1 Million USD | 61.35% |
| 1993 Q4 | 26.8 Million USD | 12.61% |
| 1993 Q1 | 19.5 Million USD | 18.9% |
| 1993 Q3 | 23.8 Million USD | 3.03% |
| 1992 Q3 | 14.7 Million USD | -0.68% |
| 1992 Q2 | 14.8 Million USD | 25.42% |
| 1992 Q1 | 11.8 Million USD | 26.88% |
| 1992 Q4 | 16.4 Million USD | 11.56% |
| 1992 FY | 57.7 Million USD | 89.18% |
| 1991 Q3 | 7.5 Million USD | 1.35% |
| 1991 FY | 30.5 Million USD | 0.0% |
| 1991 Q1 | 6.3 Million USD | 0.0% |
| 1991 Q4 | 9.3 Million USD | 24.0% |
| 1991 Q2 | 7.4 Million USD | 17.46% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Phreesia, Inc. | 356.29 Million USD | -927.495% |
| Accuray Incorporated | 446.55 Million USD | -719.829% |
| Align Technology, Inc. | 3.86 Billion USD | 5.212% |
| Elevance Health Inc. | 171.34 Billion USD | 97.863% |
| AxoGen, Inc. | 159.01 Million USD | -2202.312% |
| Boston Scientific Corporation | 14.24 Billion USD | 74.291% |
| CVS Health Corporation | 357.77 Billion USD | 98.977% |
| Cardinal Health, Inc. | 226.82 Billion USD | 98.386% |
| Centene Corporation | 141.26 Billion USD | 97.408% |
| DaVita Inc. | 12.14 Billion USD | 69.844% |
| HCA Healthcare, Inc. | 64.96 Billion USD | 94.365% |
| Hologic, Inc. | 4.03 Billion USD | 9.164% |
| Humana Inc. | 106.37 Billion USD | 96.558% |
| Laboratory Corporation of America Holdings | 12.16 Billion USD | 69.897% |
| Masimo Corporation | 2.04 Billion USD | -78.749% |
| McKesson Corporation | 308.95 Billion USD | 98.815% |
| Patterson Companies, Inc. | 6.56 Billion USD | 44.263% |
| Quest Diagnostics Incorporated | 9.25 Billion USD | 60.431% |
| ResMed Inc. | 4.68 Billion USD | 21.863% |
| Henry Schein, Inc. | 12.33 Billion USD | 70.33% |
| Teladoc Health, Inc. | 2.6 Billion USD | -40.675% |
| Universal Health Services, Inc. | 14.28 Billion USD | 74.367% |
| Veeva Systems Inc. | 2.36 Billion USD | -54.884% |
| Baxter International Inc. | 14.81 Billion USD | 75.286% |
| Becton, Dickinson and Company | 19.37 Billion USD | 81.102% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 48.612% |
| Danaher Corporation | 23.89 Billion USD | 84.676% |
| Stryker Corporation | 20.49 Billion USD | 82.14% |
| Medtronic plc | 32.36 Billion USD | 88.688% |